Alpharma

Bloomberg is reporting that Pfizer, Inc. (NYSE: PFE) has agreed to pay $3.6 billion in cash to buy King Pharmaceuticals, Inc. (NYSE: KG). The deal will cost Pfizer $14.25 per share – a 40% premium over yesterday's closing price. Bloomberg says that Pfizer needs new products to help offset the...